Replies to post #248531 on Biotech Values

[edcoolidge]

Jake takes an objective viewpoint by looking at the share price and commenting on it.

[WorstLuck]

To get to that level ($10) they would have to commit to burning a good chunk of cash. They clearly aren't close enough on a 235 partnership and the street doubts that it is coming. RSV wasn't exciting before the current trials so it isn't clear what the picture will look like after readouts. I guess the challenge trial for the L compound could increase interest. TBD.

[edcoolidge]

$ENTA is recovering. Next stop $20 🚀🚀🚀. <--- this is an extremely low quality comment and should be deleted along with the message it is replying to.